Description

BSE announces listing of 15,000 Commercial Papers of Rs. 5 lakhs each issued by Poonawalla Fincorp Limited on private placement basis, effective November 26, 2025.

Summary

BSE has listed new Commercial Papers issued by POONAWALLA FINCORP LIMITED on private placement basis, effective November 26, 2025. The listing comprises 15,000 Commercial Papers with face value of Rs. 5,00,000 each, totaling Rs. 7,500 crores. The securities are rated CARE A1+ and CRISIL A1+ and will be traded in dematerialized form only on the BSE Debt segment.

Key Points

  • 15,000 Commercial Papers listed with face value of Rs. 5,00,000 each
  • Scrip Code: 730653, Scrip ID: PFL251125
  • ISIN Number: INE511C14ZC0
  • Credit Rating: CARE A1+, CRISIL A1+
  • Issue Price: Rs. 4,91,881.50 per unit
  • Market Lot: 1 unit
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Issuing and Paying Agent: ICICI BANK LTD

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE511C14ZC0
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Tick size of 1 paise must be followed for all transactions

Important Dates

  • Allotment Date: November 25, 2025
  • Listing Date: November 26, 2025
  • Redemption Date: February 24, 2026
  • Tenure: 91 days

Impact Assessment

This is a routine debt instrument listing with minimal market impact. The Commercial Papers provide short-term financing to Poonawalla Fincorp Limited and offer investment opportunities for debt market participants. The high credit ratings (A1+) indicate strong creditworthiness. The listing affects only debt segment trading members and does not impact equity markets or require any operational changes beyond standard debt trading procedures.

Impact Justification

Routine listing of commercial paper on debt segment with no impact on equity markets or broader compliance requirements